Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO C
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
BERISSO G
MORDINI N
INCAGLIATO M
FUGAZZA G
SESSAREGO M
BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903
Authors:
CARELLA AM
LERMA E
DEJANA A
CORSETTI MT
CELESTI L
BRUNI R
BENVENUTO F
FIGARI O
PARODI C
CARLIER P
FLORIO G
LERCARI G
VALBONESI M
CASARINO L
DESTEFANO F
GENIRAM A
VENTURINO M
TEDESCHI L
PALMIERI G
PIAGGIO G
PODESTA M
FRASSONI F
VANLINT MT
MARMONT AM
BACIGALUPO A
Citation: Am. Carella et al., ENGRAFTMENT OF HLA-MATCHED SIBLING HEMATOPOIETIC STEM-CELLS AFTER IMMUNOSUPPRESSIVE CONDITIONING REGIMEN IN PATIENTS WITH HEMATOLOGIC NEOPLASIAS, Haematologica, 83(10), 1998, pp. 904-909
Authors:
BACIGALUPO A
BROCCIA G
CORDA G
ARCESE W
DIBONA E
CAROTENUTO M
GALLAMINI A
LOCATELLI F
MORI P
SARACCO P
TODESCHINI G
COSER P
IACOPINO P
VANLINT MT
Citation: A. Bacigalupo et al., LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 235-235
Authors:
MARINA P
PIAGGIO G
FRASSONI F
PITTO A
ZIKOS P
SESSAREGO M
ABATE M
VANLINT MT
BERISSO G
BACIGALUPO A
Citation: P. Marina et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY (IS) OR BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 415-415
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414
Authors:
MARMONT AM
VANLINT MT
OCCHINI D
LAMPARELLI T
BACIGALUPO A
Citation: Am. Marmont et al., FAILURE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN REFRACTORY THROMBOCYTOPENIC PURPURA, Bone marrow transplantation, 22(8), 1998, pp. 827-828
Authors:
MORETTI S
ZIKOS P
VANLINT MT
TEDONE E
OCCHINI D
GUALANDI F
LAMPARELLI T
MORDINI N
BERISSO G
BREGANTE S
BRUNO B
BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180
Authors:
MACHETTI M
FEASI M
MORDINI N
VANLINT MT
BACIGALUPO A
LATGE JP
SARFATI J
VISCOLI C
Citation: M. Machetti et al., COMPARISON OF AN ENZYME-IMMUNOASSAY AND A LATEX AGGLUTINATION SYSTEM FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21(9), 1998, pp. 917-921
Authors:
COHEN A
ROVELLI R
ZECCA S
VANLINT MT
PARODI L
GRASSO L
UDERZO C
Citation: A. Cohen et al., ENDOCRINE LATE EFFECTS IN CHILDREN WHO UNDERWENT BONE-MARROW TRANSPLANTATION - REVIEW, Bone marrow transplantation, 21, 1998, pp. 64-67
Authors:
BOSI A
BACCI S
LASZLO D
LOCATELLI F
MESSORI A
VANLINT MT
DIBARTOLOMEO P
AMICI A
Citation: A. Bosi et al., COST-EFFECTIVENESS OF 2ND ALLOGENEIC BONE-MARROW TRANSPLANTATION (2BMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), Bone marrow transplantation, 21, 1998, pp. 14-14
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38
Authors:
ZIKOS PM
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
BERISSO G
MORDINI N
INCAGLIATO M
FUGAZZA G
SESSAREGO M
VITALE V
BARRA S
CORVO R
BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121
Authors:
BACIGALUPO A
BRAND R
SOCIE G
PASSY J
LOCASCIULLI A
VANLINT MT
TICHELLI A
MCCANN S
MARSH J",LJUNDGMAN,"HOWS J
MARIN P
SCHREZENMEIER H
Citation: A. Bacigalupo et al., BONE-MARROW TRANSPLANTATION (BMT) OR IMMUNOSUPPRESSIVE THERAPY (IS) FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA (SAA) - A REPORT OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTS (EBMT) SAA WORKING PARTY, Bone marrow transplantation, 21, 1998, pp. 177-177
Authors:
BERISSO GA
VANLINT MT
OCCHINI D
GUALANDI F
BACIGALUPO A
MARMONT AM
Citation: Ga. Berisso et al., ADOPTIVE DEVELOPMENT OF DIFFERENT ANTITHYROID AUTOANTIBODIES FOLLOWING ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 192-192
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357
Authors:
KLIMOVITCH A
KRUTETSKAYA I
VANLINT MT
SAMOILOVICH M
AFANASIEV B
PODOLTSEVA E
KLIMOVITCH V
Citation: A. Klimovitch et al., SERUM LEVELS OF THE IGG-SUBCLASSES AND TOTAL IGE IN EARLY POSTTRANSPLANTATION PERIOD IN ALLO-BMT, Bone marrow transplantation, 21, 1998, pp. 393-393
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490
Authors:
COHEN A
ROVELLI A
UDERZO C
VANLINT MT
SOCIE G
GAIERO A
BAKKER B
CAHN JY
DOPFER R
ESPEROU H
LEIPER A
VOSSEN JM
KOLB HJ
Citation: A. Cohen et al., FINAL RESULTS FROM THE STUDY OF THE WORKING PARTY FOR LATE EFFECTS ONFINAL HEIGHT OF PATIENTS WHO UNDERWENT BMT DURING CHILDHOOD, Bone marrow transplantation, 21, 1998, pp. 569-569
Authors:
VANLINT MT
UDERZO C
LOCASCIULLI A
MAJOLINO I
SCIME R
LOCATELLI F
GIORGIANI G
ARCESE W
IORI AP
FALDA M
LOCATELLI F
BOSI A
MINIERO R
ALESSANDRINO P
DINI G
ROTOLI B
BACIGALUPO A
Citation: Mt. Vanlint et al., EARLY TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HIGH-DOSE OR LOW-DOSE 6-METHYLPREDNISOLONE - A MULTICENTER RANDOMIZED TRIAL FROM THE ITALIAN GROUP FOR BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2288-2293
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
DESTEFANO F
SORACCO M
VITALE V
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508
Authors:
PODESTA M
PIAGGIO G
FRASSONI F
PITTO A
ZIKOS P
SESSAREGO M
ABATE M
VANLINT MT
BERISSO G
BACIGALUPO A
Citation: M. Podesta et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY OR BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA, Blood, 91(6), 1998, pp. 1959-1965